Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C4B anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement C4B dans IF et IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN6936545

Aperçu rapide pour C4B anticorps (ABIN6936545)

Antigène

Voir toutes C4B (C4b) Anticorps
C4B (C4b) (Complement Component C4b (C4b))

Reactivité

  • 46
  • 20
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 57
  • 4
  • 3
Souris

Clonalité

  • 60
  • 4
Monoclonal

Conjugué

  • 23
  • 8
  • 7
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp C4B est non-conjugé

Application

  • 32
  • 19
  • 19
  • 13
  • 13
  • 11
  • 6
  • 6
  • 6
  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

SPM545
  • Specificité

    This MAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human Complement 4d protein

    Isotype

    IgG1 kappa
  • Indications d'application

    Known_Application: Immunofluorescence (1:50-1:100), Immunohistochemistry (Formalin-fixed) (1:200-1:400 for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 1 mM EDTA, pH 7.5-8.5, for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: Rejected Renal Transplant Tissue.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    C4B (C4b) (Complement Component C4b (C4b))

    Autre désignation

    C4B

    Sujet

    Acidic Complement C4, Basic C4, C4, C4-1, C4a Anaphylatoxin, C4A, C4A2, C4A3, C4A4, C4A6, C4b, C4B1, C4B12, C4d fragment, C4F, C4S, Complement C4 Gamma Chain, Complement Component 4A, Complement Component 4B,Complement 4d (C4d) (Acute Humoral Rejection Marker)
    Cellular localisation: Intracytoplasmic vacuoles of endothelial cells and Secreted

    Poids moléculaire

    192kDa (predicted)

    ID gène

    720, 721, 534847

    Pathways

    Système du Complément
Vous êtes ici:
Chat with us!